KIMIA FARMA -B-
PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and markets chemical, betalactam and non betalactam, antiretr… Read more
KIMIA FARMA -B- (HQP) - Total Liabilities
Latest total liabilities as of June 2025: €11.68 Trillion EUR
Based on the latest financial reports, KIMIA FARMA -B- (HQP) has total liabilities worth €11.68 Trillion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
KIMIA FARMA -B- - Total Liabilities Trend (2016–2024)
This chart illustrates how KIMIA FARMA -B-'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
KIMIA FARMA -B- Competitors by Total Liabilities
The table below lists competitors of KIMIA FARMA -B- ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Taj GVK Hotels & Resorts Limited
NSE:TAJGVK
|
India | ₹2.76 Billion |
|
Ching Feng Home Fashions Co Ltd
TW:9935
|
Taiwan | NT$5.19 Billion |
|
Neptune Digital Assets Corp
PINK:NPPTF
|
USA | $13.51 Million |
|
Bank Multiarta Sentosa PT
JK:MASB
|
Indonesia | Rp29.51 Trillion |
|
Welldone Co
TWO:6170
|
Taiwan | NT$3.30 Billion |
|
Softstar Entertainment
TWO:6111
|
Taiwan | NT$21.35 Billion |
|
Frontier Lithium Inc
OTCQX:LITOF
|
USA | $36.14 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down KIMIA FARMA -B-'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how KIMIA FARMA -B-'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for KIMIA FARMA -B- (2016–2024)
The table below shows the annual total liabilities of KIMIA FARMA -B- from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €11.54 Trillion | -2.65% |
| 2023-12-31 | €11.85 Trillion | +0.49% |
| 2022-12-31 | €11.79 Trillion | +4.01% |
| 2021-12-31 | €11.34 Trillion | +8.44% |
| 2020-12-31 | €10.46 Trillion | -4.41% |
| 2019-12-31 | €10.94 Trillion | +79.23% |
| 2018-12-31 | €6.10 Trillion | +73.23% |
| 2017-12-31 | €3.52 Trillion | +50.51% |
| 2016-12-31 | €2.34 Trillion | -- |